Former Receptos CEO Faheem Hasnain, pictured in this 2015 file photo, has grown several biotech companies that were acquired by industry giants. Hasnain, now the CEO of Gossamer Bio, said employee continuity is a key factor in smooth biotech acquisitions.

Former Receptos CEO Faheem Hasnain, pictured in this 2015 file photo, has grown several biotech companies that were acquired by industry giants. Hasnain, now the CEO of Gossamer Bio, said employee continuity is a key factor in smooth biotech acquisitions. Photo by Melissa Jacobs.

— Earlier this month, an executive from New Jersey-based Celgene blamed Receptos, a San Diego firm that it bought, for a major regulatory setback...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129